Orbital Diseases
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) (NCT05276063) | Sling Therapeutics, Inc. | 2022-07-01 |
| Ocular Manifestations in Rheumatic Diseases (NCT03753893) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2013-05-01 |
| AI-Assisted Facial Surgical Planning (NCT04319055) | National Taiwan University Hospital | 2009-01-01 |
Track Orbital Diseases automatically
Every clearance here is in the API, with alerts when new ones post.